Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control.
Harper-Wynne
C L
CL
Sumpter
K
K
Ryan
C
C
Priest
K
K
Norton
A
A
Ross
P
P
Ford
H E R
HE
Johnson
P
P
O'Brien
M E R
ME
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009161:Mycobacterium; D016019:Survival Analysis
D001428:Bacterial Vaccines; C451081:SRL172